Jump to content

Imre Kacskovics

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tom.Reding (talk | contribs) at 14:00, 5 October 2023 (+{{Authority control}} (3 IDs from Wikidata); cleanup & WP:GenFixes on, typo(s) fixed: 75-86 → 75–86 (2)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Imre Kacskovics
Born23 September 1961
NationalityHungarian
CitizenshipHungarian
Occupationacademic
Academic background
EducationEötvös Loránd University
Alma materUniversity of Veterinary Medicine Budapest
Budapest University of Technology and Economics
Eötvös Loránd University
Academic work
DisciplineImmunology
InstitutionsEötvös Loránd University

Imre Kacskovics (23 September 1961, Budapest) is a Hungarian immunologist and the current dean of the Faculty of Science of the Eötvös Loránd University.[1][2]

Life

He was born in 1961 in Budapest and he has been married with 3 children.

Teaching career

He obtained a degree in veterinary in 1987 from the University of Veterinary Medicine Budapest. In 1991, he obtained a degree in nuclear technology and radiation from the Budapest University of Technology and Economics. In 1998, he obtained a Doctor of Philosophy from the University of Veterinary Medicine Budapest.[3] His thesis was entitled The examination of the VH and CH immunoglobin genes of the pigs (in Hungarian: A sertés VH és CH immunglobulin génjeinek vizsgálata).

In 1999, he was a Visiting scholar at the Brandeis University, Massachusetts, United States.[4]

In 2019, he was appointed as the Dean of the ELTE Faculty of Science.[5]

Research

During the COVID-19 pandemic in Hungary, he worked as a consultant for Hungarian prime minister Viktor Orbán.[6][7] He was interviewed several times during the pandemic.[8][9] In 2020, he was interviewed by Politico.[10]

He was appointed as the Head of the Drug Development Consortium working under the auspices of the Ministry of Innovation and Technology.[11] In October 2021, he said that the Hungarian COVID drug might be tested on animals in 2023.[12]

On 13 September 2022, he delivered a speech at the MLE Citizen Science working group meeting in Budapest.[13]

Awards

  • Bolyai János Research Fellowship from the Hungarian Academy of Sciences (1998),
  • Széchenyi István Research Fellowship from the Ministry of Education of the Republic of Hungary (2001),
  • Golden Medal of Szent István University (2006)
  • "Innovative Researcher of the year 2010" from the Eötvös Loránd University[14]

Works

B Dudok, L Barna, M Ledri, SI Szabó, E Szabadits, B Pintér (2015). Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature neuroscience, 18(1), 75–86.[15]

C Fekete, B Gereben, M Doleschall, JW Harney, JM Dora, AC Bianco (2004). Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology, 145(4), 1649–1655.[16]

References

  1. ^ "Imre Kacskovics". immun.elte.hu (in Hungarian). Retrieved 2022-12-10.
  2. ^ "Faculty Leadership". ttk.elte.hu/en (in Hungarian). Retrieved 2022-12-10.
  3. ^ "Kacskovics Imre - ODT Személyi adatlap". doktori.hu (in Hungarian). Retrieved 2022-12-10.
  4. ^ "Imre Kacskovics' CV" (PDF). 10 December 2022.
  5. ^ Tóth, Bálint (2019-06-09). "Kacskovics Imre lett a Természettudományi Kar dékánja". ELTE Online (in Hungarian). Retrieved 2022-12-10.
  6. ^ "Prime Minister Viktor Orbán had talks with heads of research teams about domestic pharmaceutical production – miniszterelnok.hu". miniszterelnok.hu. Retrieved 2022-12-10.
  7. ^ Hungary, About (2020-04-03). "Coronavirus Update: PM Orbán meets with leading researchers to discuss virus". Coronavirus Update: PM Orbán meets with leading researchers to discuss virus. Retrieved 2022-12-10.
  8. ^ "Sixth Wave of Coronavirus May Arrive in Hungary in a Few Months". Hungary Today. 2022-06-22. Retrieved 2022-12-10.
  9. ^ "It's only a matter of time, and here's the fourth wave - warns the immunologist". The Budapest Herald. 2021-08-04. Retrieved 2022-12-10.
  10. ^ "These EU countries crushed coronavirus in the spring. Can they do it again?". POLITICO. 2020-09-07. Retrieved 2022-12-10.
  11. ^ "Good prospects for Hungarian coronavirus drug". Növekedés.hu. 2020-07-23. Retrieved 2022-12-10.
  12. ^ Balogh, András (2021-10-22). "This is what the Hungarian COVID medicine will be capable of". Daily News Hungary. Retrieved 2022-12-10.
  13. ^ NKFIH (2022-10-03). "National Research, Development and Innovation Office | The first nationwide Citizen Science collaboration network has been created". nkfih.gov.hu. Retrieved 2022-12-10.
  14. ^ "Immunogenes - Prof. Dr. Imre Kacskovics". www.immunogenes.com. Retrieved 2022-12-10.
  15. ^ Dudok, Barna; Barna, László; Ledri, Marco; Szabó, Szilárd I.; Szabadits, Eszter; Pintér, Balázs; Woodhams, Stephen G.; Henstridge, Christopher M.; Balla, Gyula Y.; Nyilas, Rita; Varga, Csaba; Lee, Sang-Hun; Matolcsi, Máté; Cervenak, Judit; Kacskovics, Imre (January 2015). "Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling". Nature Neuroscience. 18 (1): 75–86. doi:10.1038/nn.3892. ISSN 1546-1726. PMC 4281300. PMID 25485758.
  16. ^ Fekete, Csaba; Gereben, Balázs; Doleschall, Márton; Harney, John W.; Dora, Jose Miguel; Bianco, Antonio C.; Sarkar, Sumit; Liposits, Zsolt; Rand, William; Emerson, Charles; Kacskovics, Imre; Larsen, P. Reed; Lechan, Ronald M. (2004). "Lipopolysaccharide Induces Type 2 Iodothyronine Deiodinase in the Mediobasal Hypothalamus: Implications for the Nonthyroidal Illness Syndrome". Endocrinology. 145 (4): 1649–1655. doi:10.1210/en.2003-1439. PMID 14684601. S2CID 18184984. Retrieved 2022-12-10.